Recommendation For Emergency Use Authorization Of Janssen (Johnson & Johnson) Covid-19 Vaccine
, The National Agency for Food and Drug Administration and Control (NAFDAC) is hereby granting conditional Emergency Use Authorization for Janssen COVID-19 Vaccine to prevent COVID-19 in people from eighteen (18) years of age. After a thorough evaluation, the NAFDAC Vaccine Committee concluded that the data on the vaccine were robust and met criteria for […]
